Laboratório de Eletrofisiologia e Farmacologia Cardiovascular, Faculdade de Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, MS, Brazil.
Laboratório de Pesquisa Pré-Clínica em Produtos Naturais, Universidade Paranaense, Umuarama, PR, Brazil.
Phytomedicine. 2019 Mar 15;56:74-82. doi: 10.1016/j.phymed.2018.08.014. Epub 2018 Aug 11.
Luehea divaricata Mart. (Malvaceae) is an important medicinal species widely used by indigenous and riverside populations of the Brazilian Pantanal region. It has been shown that the several extracts obtained from leaves of this species have important cardioprotective effects. Nevertheless, the secondary metabolites responsible for this activity, as well as the molecular mechanisms responsible for their pharmacological effects remain unknown.
To carry out a biomonitoring study to identify possible active metabolites present in different ESLD fractions and evaluate the mechanisms responsible for the vasodilatory effects on isolated perfused mesenteric beds.
First, ESLD was obtained from L. divaricata leaves and a liquid-liquid fractionation was performed. The resulting fractions were analyzed by liquid chromatography-mass spectrometry. Then, the possible vasodilatory effects of ESLD, chloroform, ethyl acetate, n-butanolic and aqueous fractions on perfused arterial mesenteric vascular beds were evaluated. Finally, the molecular mechanisms involved in vasodilator responses of the aqueous fraction and its chemical component, isovitexin, on the mesenteric arteriolar tone were also investigated.
In preparations with functional endothelium ESLD, n-butanolic, aqueous fraction and isovitexin dose-dependently reduced the perfusion pressure in mesenteric vascular beds. Endothelium removal or inhibition of nitric oxide synthase enzymes by L-NAME reduced the vasodilatory effects induced by aqueous fraction and isovitexin. Perfusion with nutritive solution containing 40 mM KCl abolished the vasodilatory effect of all aqueous fractions and Isovitexin doses. Treatment with glibenclamide, a Kir6.1 (ATP-sensitive) potassium channels blocker, tetraethylammonium, a non-selective KCa (calcium-activated) potassium channels blocker, or apamin, a potent blocker of small conductance Ca-activated (SK KCa) potassium channels reduced by around 70% vasodilation induced by all aqueous fractions and isovitexin doses. In addition, association of tetraethylammonium and glibenclamide, or L-NAME and glibenclamide, fully inhibited aqueous fraction and Isovitexin -induced vasodilation.
This study showed that AqueFr obtained from Luehea divaricata and its metabolite - isovitexin - has important vasodilatory effects on MVBs. Apparently, these effects are dependent on endothelium-NO release and both SK KCa K channels and Kir6.1 ATP-sensitive K channels activation in the vascular smooth muscle.
Luehea divaricata Mart.(锦葵科)是一种重要的药用物种,被巴西潘塔纳尔地区的土著和河边居民广泛使用。已经表明,从该物种叶子中获得的几种提取物具有重要的心脏保护作用。然而,负责这种活性的次生代谢物以及负责其药理作用的分子机制仍然未知。
进行生物监测研究,以鉴定存在于不同 ESLD 级分中的可能的活性代谢物,并评估其对分离的灌注肠系膜床的血管舒张作用的机制。
首先,从 L. divaricata 叶子中获得 ESLD,并进行液-液分馏。所得馏分通过液相色谱-质谱分析。然后,评估 ESLD、氯仿、乙酸乙酯、正丁醇和水相 fractions 对灌注的肠系膜血管床的可能的血管舒张作用。最后,还研究了水相 fraction 及其化学组分异荭草苷对肠系膜小动脉张力的血管舒张反应的分子机制。
在具有功能内皮的制剂中,ESLD、正丁醇、水相 fraction 和异荭草苷剂量依赖性地降低肠系膜血管床的灌注压。内皮去除或一氧化氮合酶抑制剂 L-NAME 降低了水相 fraction 和异荭草苷诱导的血管舒张作用。用含有 40mM KCl 的营养溶液灌注完全消除了所有水相 fraction 和异荭草苷剂量的血管舒张作用。用格列本脲(Kir6.1(ATP 敏感)钾通道阻滞剂)、四乙铵(非选择性 KCa(钙激活)钾通道阻滞剂)或 apamin(强效小电导钙激活(SK KCa)钾通道阻滞剂)处理,可使所有水相 fraction 和异荭草苷剂量诱导的血管舒张作用降低约 70%。此外,四乙铵和格列本脲的联合,或 L-NAME 和格列本脲的联合,完全抑制了水相 fraction 和异荭草苷诱导的血管舒张作用。
本研究表明,从 Luehea divaricata 获得的 AqueFr 及其代谢物-异荭草苷对 MVBs 具有重要的血管舒张作用。显然,这些作用依赖于内皮-N0 释放以及血管平滑肌中 SK KCa K 通道和 Kir6.1 ATP 敏感 K 通道的激活。